Last Updated on March 16, 2024

[Show slideshow]

Atomoxetine is a prescription medication used to treat attention deficit hyperactivity disorder (ADHD) in both adults and children. It works by increasing the levels of certain chemicals in the brain that control attention and impulse control. Atomoxetine is not considered a controlled substance, but it is still a prescription-only medication in the UK. This means that you cannot buy it over the counter without a prescription from a doctor.

However, there are certain online pharmacies that claim to sell atomoxetine without a prescription. It is important to note that buying prescription medications without a valid prescription is illegal and can be dangerous. You may receive a counterfeit or expired medication that could harm your health. Additionally, purchasing medications from unregulated sources can also put your personal and financial information at risk.

If you have been diagnosed with ADHD and your doctor has prescribed atomoxetine, you can obtain it from a licensed pharmacy with a valid prescription. You may also be able to order it online from regulated pharmacies that require a prescription. Always make sure that you are purchasing medications from reputable sources to ensure that you are getting the correct medication and dosage for your condition.

Buy atomoxetine from BuyOvertheCounterUK.net and get high quality drug on reduced worldwide prices. BuyOvertheCounterUK.net gives you the chance to purchase cheap atomoxetine online and find out more about atomoxetine side effects, dosage info and drug interactions. Ask your pharmacist any questions you’ve got relating to this medication, especially if it’s new to you.

What is atomoxetine?

Atomoxetine is used to treat attention deficit/hyperactivity disorder (ADHD). It is not classified to other drugs for ADHD treatment as an anesthetic in contrast and has no dependence potential. Here you can read everything about Atomoxetine: effects, dosage, use and possible side effects.

How does atomoxetine work?

Attention Deficit Hyperactivity Disorder (ADHD), also known as Attention Deficit Hyperactivity Disorder (ADHD), usually begins in childhood and consists of a variety of symptoms. People with ADHD typically have limited attention span, increased impulsivity, and physical restlessness. The extent of the mental disorder determines whether psychotherapeutic or pharmacological treatment is necessary.

Of the stimulants typically used in ADHD treatment (such as methylphenidate and amphetamine), atomoxetine differs significantly. The mentioned stimulants increase concentration of certain messengers in the brain (mainly of norepinephrine and) communicate through the nerve cells (neurons) together. Thus, the symptoms of ADHD get better.

The active ingredient atomoxetine, which is chemically very similar to the antidepressant fluoxetine, occupies an intermediate position between ADHD medication and antidepressant. Like antidepressants, it takes a few weeks to take effect, but atomoxetine does not act as an antidepressant. Rather, it acts in the brain as a selective norepinephrine reuptake inhibitor (NARI). This increases the concentration of this neurotransmitter. The dopamine hormone balance is not affected to a relevant extent. Experts believe that atomoxetine, among other drugs, has no addiction potential – it works in a staggered manner and does not cause an immediate payout of the “happiness hormone” dopamine.

Another effect that still needs to be studied in detail is the effect of atomoxetine on the so-called NMDA receptors in the brain. Scientists currently believe that this neurotransmitter is also involved in the development of ADHD.

Absorption, elimination, and metabolism of atomoxetine

Once taken by mouth, atomoxetine is rapidly absorbed through the intestinal mucosa into the blood. There it reaches the highest levels after one to two hours. In the liver, atomoxetine is broken down by the enzyme cytochrome 2D6, whereupon it is rapidly excreted in the urine. However, about seven percent of the Caucasian population have this enzyme in a variant that works less well, so the degradation and excretion of atomoxetine may be delayed. Therefore, a very low dose of atomoxetine is chosen at the beginning of treatment and gradually increased. In patients with normal enzyme activity, about half of the drug is excreted in the urine within three and a half hours.

When should you use atomoxetine?

Atomoxetine is used for treating ADHD in children as young as six years of age, adolescents, and adults. The treatment should be performed by a physician with appropriate expertise and be part of an overall treatment plan, such as psychological, educational, and social measures.

Atomoxetine is not approved for other uses. The active ingredient, however, is used by physicians “off-label” (ie, outside the stated scope of approval) and eating disorders, depression associated with ADHD, bedwetting in children and for weight loss.

How is atomoxetine used?

Atomoxetine is usually taken as a single dose in the morning. The capsule can be taken with or without a meal with sufficient liquid. If adverse drug reactions after taking (eg, nausea), even half each morning and evening can be done.

In children and adolescents over 70 kg body weight and adults comes at the beginning usually a dose of 40 milligrams of Atomoxetine for at least one week to use. The dosage may be increased depending on the effect (this is only after two to four weeks completely a) to 80 milligrams of Atomoxetine. For children and adolescents under 70 kg, the dosage should be reduced accordingly. The manufacturer’s recommended maximum daily dose is 100 milligrams of active ingredient, since higher doses do not necessarily cause an increased effect.

What are the side effects atomoxetine?

More than one in ten patients experience side effects. These include decreased appetite, drowsiness, abdominal pain, nausea, vomiting, increased blood pressure, and a faster heartbeat.

With one in ten to one hundred patients experience atomoxetine side effects. These include irritability, mood swings, insomnia, indigestion, rash, itching, fatigue and weight loss.

What should I be aware of during use of atomoxetine?

Co-administration of atomoxetine and other drugs that are metabolized by the same enzyme (cytochrome 2D6) may interact, as one drug is usually metabolized preferentially while the other accumulates in the body. Examples of such drugs include antidepressants such as MAOIs (e.g., tranylcypromine, moclobemide) and SSRIs (selective serotonin reuptake inhibitors, e.g., fluoxetine, paroxetine), antiallergic drugs (e.g., terbinafine), and drugs used to treat heart rhythm problems (e.g., quinidine).

Medications that affect the heart rhythm in a certain way (a QT prolongation effect) should not be combined with atomoxetine. There are many examples of such drugs, such as drugs for psychosis and schizophrenia, drugs for heart rhythm problems, antibiotics, and antidepressants.

The effects of β ₂agonists used for acute treatment (such as salbutamol) or long-term treatment (such as salmeterol, formoterol) of asthma may be increased by the combination with atomoxetine. This may include high blood pressure and rapid heartbeat. At the same time, atomoxetine antagonize the effects of high blood pressure medicines.

Because the data for taking atomoxetine during pregnancy and lactation are limited, it should be avoided. According to animal studies, atomoxetine is found in breast milk.

As with antidepressants, use of atomoxetine in adolescents may lead to increased suicidal behavior. Adolescents at risk should be monitored.

The safe and effective use of atomoxetine in children and adolescents as young as six years of age has not been established.

Patients with hepatic impairment should be treated with a reduced dose of atomoxetine.

How can I get medicine that contains atomoxetine?

Atomoxetine is only available by prescription and is therefore only available at the pharmacy by prescription.

How long has atomoxetine been known?

Prior to its approval by the United Kingdom, Strattera was approved by the US Food and Drug Administration on November 26, 2002, for the treatment of ADHD in children, adolescents, and adults. Atomoxetine was approved in Germany in 2005 for the treatment of children and adolescents with ADHD. In 2013, the approval was extended to the treatment of adults. Since the patent protection expires at the earliest in 2017, so far only the original manufacturer (Eli Lilly and Company) sells preparations containing the active substance atomoxetine.